Form 4 for ABT Abbott Laboratories
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001805099-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABT | Boudreau Philip P | EVP AND CFO | F - Tax | $116.26 | -7,441 | 71.2K | -9% | -$865.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2026-02-27 | F | D | 7,441 | $116.26 | 71,172 | D | — | — |